July 25, 2025Open Access

Molecular Insights into HPV-Driven Head and Neck Cancers: From Viral Oncoproteins to Precision Therapeutics

View Full Paper

Ask AI

Bookmark

Authors

MÖMustafa ÖzdoğanIstanbul Memorial Hospital GTGizem TutkunAkdeniz University MÇMuharrem Okan ÇakırKingston University

Discussion

Member takes

Implication

This review highlights oncogenic mechanisms and emerging therapeutic strategies for head and neck cancers, suggesting improved outcomes for HPV-positive patients.

Key Points

HPV plays a significant role in the development of head and neck cancers, particularly oropharyngeal squamous cell carcinoma.
The oncogenic E6 and E7 proteins disrupt tumor suppressor pathways, contributing to carcinogenesis in HPV-related head and neck cancers.
HPV-positive tumors exhibit better prognosis and treatment responses, necessitating research into therapy de-escalation strategies.
Emerging therapies, such as immune checkpoint inhibitors and therapeutic vaccines, are advancing precision oncology for HPV-driven head and neck cancers.

Cite This Study

Özdoğan et al. (2025) studied this question.

synapsesocial.com/papers/689a0933e6551bb0af8ce464 https://doi.org/10.20944/preprints202507.1765.v1

View Full Paper

Ask AI

Bookmark

Implication

This review highlights oncogenic mechanisms and emerging therapeutic strategies for head and neck cancers, suggesting improved outcomes for HPV-positive patients.

Molecular Insights into HPV-Driven Head and Neck Cancers: From Viral Oncoproteins to Precision Therapeutics

Discussion

Member takes

Implication

Key Points

Cite This Study

Molecular Insights into HPV-Driven Head and Neck Cancers: From Viral Oncoproteins to Precision Therapeutics

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider